Question 1

Does RhumbLine Advisers own NTLA stock?

Accepted Answer

Yes. As of its Q2 2026 13F, RhumbLine Advisers holds 176,725 shares of NTLA (Intellia Therapeutics), worth $3M.

Question 2

How many shares of NTLA does RhumbLine Advisers own?

Accepted Answer

As of its Q2 2026 13F, RhumbLine Advisers holds 176,725 shares of NTLA (Intellia Therapeutics).

Question 3

What is RhumbLine Advisers' NTLA position worth?

Accepted Answer

As of its Q2 2026 13F, RhumbLine Advisers' NTLA position is worth $3M.

Question 4

Is RhumbLine Advisers buying or selling NTLA?

Accepted Answer

In Q2 2026, RhumbLine Advisers increased its NTLA position by 40,137 shares (+29.4%).

Question 5

When did RhumbLine Advisers first buy NTLA?

Accepted Answer

RhumbLine Advisers already held NTLA in its Q4 2018 13F, the earliest on record, and has listed it in 31 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	176,725	+29.4%	$3M	0.0%	$16.92	33
2026-Q1	Increased	136,588	+3.1%	$1.8M	0.0%	$12.82	27
2025-Q4	Decreased	132,465	-16.9%	$1.2M	0.0%	$8.99	0
2025-Q3	Decreased	159,479	-2.9%	$2.8M	0.0%	$17.27	0
2025-Q2	Increased	164,246	+4.7%	$1.5M	0.0%	$9.38	27
2025-Q1	Decreased	156,838	-5.7%	$1.1M	0.0%	$7.11	0
2024-Q4	Increased	166,248	+2.1%	$1.9M	0.0%	$11.66	26
2024-Q3	Decreased	162,749	-7.2%	$3.3M	0.0%	$20.55	0